Why IVF Fails With Good Embryos: 8 Hidden Causes of Implantation Failure
Your embryologist said the embryo was Grade AA blastocyst — but the transfer failed. Again. Here is what the grading score does not tell you, and the targeted investigations that uncover the real reason.
Quick answer: IVF can fail despite good embryo quality because successful implantation requires a receptive endometrium, correct timing (window of implantation), a normal uterine cavity, a functioning immune environment, intact clotting regulation, and healthy sperm DNA. The ERA test identifies displaced WOI in ~25% of recurrent implantation failure (RIF) patients; hysteroscopy detects uterine cavity problems in 30–40%; and thrombophilia or elevated NK cells account for a further subset. Identifying and treating the specific cause raises live birth rates substantially.
What Is Recurrent Implantation Failure (RIF)?
The reproductive medicine community defines recurrent implantation failure (RIF) as the failure of ≥2 high-quality blastocyst transfers, or ≥3 embryo transfers of any grade, without achieving a clinical pregnancy. It is distinct from recurrent miscarriage, where implantation occurs but the pregnancy then fails.
The embryo grades your embryologist reports — AA, AB, BB — reflect morphology (appearance) under the microscope. They do not measure the embryo's chromosomal status, the endometrial environment it lands in, or the immune and vascular conditions governing the first week of implantation. Any of those unscored factors can silently derail the process.
The 8 Root Causes of Implantation Failure
1. Displaced Window of Implantation (WOI)
The endometrium is receptive for only 24–48 hours, called the WOI. In up to 25% of RIF patients, this window shifts earlier or later than the standard protocol assumes. The ERA test identifies the patient-specific WOI with a genomic biopsy of 248 genes, enabling personalised embryo transfer (pET) timed precisely to the receptive phase.
2. Thin or Unreceptive Endometrium
Endometrial thickness below 7 mm at transfer is associated with lower implantation rates. Causes include inadequate oestrogen response, intrauterine adhesions (Asherman's syndrome), or previous uterine surgeries. PRP instillation, sildenafil suppositories, and hysteroscopic adhesiolysis can restore lining thickness and receptivity in many women.
3. Uterine Cavity Anomalies
Endometrial polyps, submucosal fibroids, intrauterine adhesions, and a uterine septum all physically obstruct embryo adhesion or alter the local hormonal environment. Office hysteroscopy detects these in 30–40% of RIF patients. Polypectomy and myomectomy by hysteroscope can be performed in the same outpatient session.
4. Elevated Uterine NK Cells
Uterine natural killer (uNK) cells normally regulate trophoblast invasion. When uNK counts are elevated (>5% CD56+ on endometrial biopsy), the immune environment becomes hostile to the embryo. Prednisolone, intralipid infusion, or IVIG therapy modulates uNK activity and has been shown to improve implantation in selected patients with documented elevation.
5. Thrombophilia & Antiphospholipid Syndrome
Inherited or acquired clotting disorders reduce blood flow in the micro-vessels supplying the implantation site. Antiphospholipid syndrome (APAS) is the most clinically significant: it impairs trophoblast migration and spiral artery remodelling. Low-molecular-weight heparin (LMWH) combined with low-dose aspirin from the start of a transfer cycle significantly improves outcomes in APAS-positive patients.
6. High Sperm DNA Fragmentation (DFI)
Even a morphologically normal sperm carrying a fragmented DNA strand can fertilise an egg but produce an embryo incapable of completing blastocyst development or hatching. DFI above 25% is linked to recurrent implantation failure and early miscarriage. PICSI or MACS sperm selection, antioxidant therapy for 90 days, or TESA to retrieve testicular sperm with lower DFI are the main corrective strategies. This cause is often overlooked when the focus stays entirely on the female partner.
7. Embryo Chromosomal Aneuploidy
Even good-looking blastocysts can carry chromosomal errors invisible to morphological grading — particularly in women over 37. PGT-A (preimplantation genetic testing for aneuploidy) screens embryos before transfer and selects euploid (chromosomally normal) ones. In women ≥38 with repeated failure, PGT-A can increase live birth rates per transfer by 30–50% by eliminating aneuploid transfers that would never implant.
8. Chronic Endometritis
A low-grade bacterial infection of the endometrium — often symptomless — disrupts the uterine microbiome and inflammatory environment. Plasma cell infiltration on CD138-stained hysteroscopy biopsy confirms the diagnosis. A targeted course of antibiotics (doxycycline or hysteroscopy-guided culture-directed therapy) resolves the infection and markedly improves subsequent implantation rates, with studies reporting live birth rates improving from ~9% to ~57% after treatment.
The Diagnostic Workup for Recurrent Implantation Failure
At Mother Hospitals Hyderabad, the RIF workup is personalised based on history. The standard investigation pathway covers:
| Investigation | What it detects | When recommended |
|---|---|---|
| ERA (Endometrial Receptivity Analysis) | Displaced window of implantation | After ≥2 failed good-quality blastocyst transfers |
| Office Hysteroscopy | Polyps, fibroids, adhesions, septum | Before any FET cycle after first failure |
| Endometrial Biopsy (CD138 stain) | Chronic endometritis (plasma cells) | Unexplained RIF after structural clearance |
| Uterine NK Cell Assay | Elevated uNK count (CD56+) | After 2+ failed transfers, abnormal immune history |
| Thrombophilia Panel | APAS, Factor V Leiden, MTHFR, Protein C/S | All RIF patients; mandatory if prior miscarriage |
| Sperm DFI (SCSA / TUNEL) | Paternal DNA damage contribution | After ≥2 failures — male partner often not yet tested |
| PGT-A | Embryo chromosomal aneuploidy | Age ≥37, or 3+ prior failures regardless of age |
Understanding the ERA Test: How WOI Personalisation Works
In a mock FET cycle, the endometrium is prepared with oestrogen and progesterone exactly as for a real transfer. On the day that would normally be "transfer day," a small biopsy is taken instead. The sample is couriered to the ERA laboratory (Igenomix), where the expression pattern of 248 endometrial receptivity genes is compared against validated reference profiles.
- Receptive: Proceed with transfer on the standard protocol
- Pre-receptive: WOI opens later — delay transfer by 12–24 hours
- Post-receptive: WOI closes early — advance transfer by 12–24 hours
A pET cycle using the personalised transfer time follows at the next attempt. The result from the mock cycle applies to all future FET cycles — no repeat biopsy needed unless hormonal protocol changes.
Personalised Treatment Pathway for RIF
-
Structural clearance: Office Hysteroscopy
Every RIF workup begins here. Even if a previous ultrasound appeared normal, hysteroscopy has a 30–40% anomaly detection rate in RIF patients. Correctable findings (polyps, small fibroids, thin septum) are treated in the same outpatient session under local anaesthetic.
-
WOI timing: ERA + personalised embryo transfer (pET)
If structural clearance is clear and ≥2 blastocyst transfers have failed, ERA is the next priority investigation. The pET cycle timed to the patient's personalised WOI achieves a 25% improvement in live birth rates among the ~25% of RIF patients with displaced WOI.
-
Immunological modulation
For documented elevated uNK cells: low-dose prednisolone from start of FET, or intralipid infusion before and after transfer. For chronic endometritis confirmed on CD138 biopsy: targeted antibiotics, repeated biopsy to confirm resolution before next transfer.
-
Anticoagulation for thrombophilia
LMWH (e.g. enoxaparin 40 mg once daily) from day of transfer, combined with low-dose aspirin from start of stimulation, is standard protocol for APAS-positive patients and those with multiple clotting risk factors. Continued through first trimester in pregnancy.
-
Paternal factor correction
If DFI is elevated (>25%): 90-day antioxidant course (CoQ10 300 mg, Vit C+E, Selenium, NAC), lifestyle changes, followed by repeat DFI test. For persistently high DFI: PICSI or MACS selection, or TESA to retrieve testicular sperm with inherently lower DFI than ejaculated sperm.
-
PGT-A for chromosomal selection
For women ≥38, or patients with ≥3 failures regardless of age, IVF with PGT-A ensures only euploid embryos are transferred. When a euploid embryo is available, per-transfer live birth rates are 50–60% even in older patients — eliminating the largest single cause of IVF failure.
When to Seek a Specialist RIF Review
- Two or more Grade AA/AB blastocyst transfers failed without a reason given
- Positive beta-hCG but pregnancy did not progress past 5–6 weeks (biochemical pregnancy)
- Normal semen analysis but DFI test has never been done
- Previous diagnosis of endometriosis, fibroids, or PCOS with ongoing implantation failures
- Transferred embryos in your 30s but failing to implant — age alone is unlikely; investigate further
Patients with endometriosis face additional implantation challenges beyond standard RIF causes — altered peritoneal environment, elevated oxidative stress, and ovarian reserve impact all compound the problem. Read the dedicated guide: IVF with Endometriosis: Success Rates by Stage.
If recurrent miscarriage is part of your history, the thrombophilia workup and genetic testing overlap substantially with RIF investigation — a combined review at our recurrent loss clinic covers both in a single visit.